Project Details
Description
The effect of 6 months migalastat treatment on podocyte globotriaosylceramide inclusion content, independent of mosaicism, in females with Fabry disease and amenable GLA mutations
| Status | Finished |
|---|---|
| Effective start/end date | 6/5/18 → 6/4/19 |
Funding
- UNIVERSITY OF WASHINGTON
- AMICUS THERAPEUTICS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.